{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T21:16:26Z","timestamp":1785618986779,"version":"3.56.0"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"NII Core"},{"DOI":"10.13039\/501100001407","name":"DBT","doi-asserted-by":"publisher","award":["BT\/PR5474\/MED\/30\/824\/2012"],"award-info":[{"award-number":["BT\/PR5474\/MED\/30\/824\/2012"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.bone.2019.02.019","type":"journal-article","created":{"date-parts":[[2019,2,23]],"date-time":"2019-02-23T14:26:11Z","timestamp":1550931971000},"page":"123-135","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Development and characterization of supramolecular calcitonin assembly and assessment of its interactions with the bone remodelling process"],"prefix":"10.1016","volume":"122","author":[{"given":"Kapil","family":"Manglani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viji","family":"Vijayan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9389-8096","authenticated-orcid":false,"given":"Chandramani","family":"Pathak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayuri","family":"Khandelwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parminder","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stalin","family":"Chellappa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijay K.","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avadhesha","family":"Surolia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarika","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2019.02.019_bb0005","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s001980050224","article-title":"Interim report and recommendations of the World Health Organization Task-Force for Osteoporosis","volume":"10","author":"Genant","year":"1999","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2019.02.019_bb0010","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1001\/jama.1941.02820220007002","article-title":"M., Postmenopausal osteoporosis","volume":"116","author":"Albright","year":"1941","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.bone.2019.02.019_bb0015","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nrendo.2011.146","article-title":"Antiresorptive therapies for osteoporosis: a clinical overview","volume":"8","author":"Chen","year":"2012","journal-title":"Nat. Rev. Endocrinol."},{"issue":"Suppl. 4","key":"10.1016\/j.bone.2019.02.019_bb0020","first-page":"S7","article-title":"Osteoporosis: review of the evidence for prevention, diagnosis and treatment and cost-effectiveness analysis","volume":"8","author":"Eddy","year":"1998","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2019.02.019_bb0025","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1007\/s00198-010-1208-3","article-title":"What is the best balance of benefits and risks among anti-resorptive therapies for postmenopausal osteoporosis?","volume":"21","author":"Miller","year":"2010","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2019.02.019_bb0030","first-page":"13","article-title":"Calcitonin","volume":"313","author":"Silverman","year":"1997","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.bone.2019.02.019_bb0035","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/BF00301940","article-title":"25 years of salmon calcitonin: from synthesis to therapeutic use","volume":"57","author":"Azria","year":"1995","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.bone.2019.02.019_bb0040","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s00198-007-0490-1","article-title":"Salmon calcitonin: a review of current and future therapeutic indications","volume":"19","author":"Chesnut","year":"2008","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2019.02.019_bb0045","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ijpharm.2015.02.003","article-title":"Formulation, stability and pharmacokinetics of sugar-based salmon calcitonin-loaded nanoporous\/nanoparticulate microparticles (NPMPs) for inhalation","volume":"483","author":"Amaro","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bone.2019.02.019_bb0050","doi-asserted-by":"crossref","first-page":"8881","DOI":"10.1016\/j.biomaterials.2012.08.047","article-title":"The use of polyion complex micelles to enhance the oral delivery of salmon calcitonin and transport mechanism across the intestinal epithelial barrier","volume":"33","author":"Li","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.bone.2019.02.019_bb0055","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/193381a0","article-title":"Calcitonin-a hormone from the parathyroid which lowers the calcium-level of the blood","volume":"193","author":"Copp","year":"1962","journal-title":"Nature"},{"key":"10.1016\/j.bone.2019.02.019_bb0060","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.febslet.2011.12.017","article-title":"Formation of supramolecular structures of a native-like protein in the presence of amphiphilic peptides: variations in aggregate morphology","volume":"586","author":"Artemova","year":"2012","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bone.2019.02.019_bb0065","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1371\/journal.pbio.0060017","article-title":"Amyloid as a depot for the formulation of long-acting drugs","volume":"6","author":"Maji","year":"2008","journal-title":"PLoS Biol."},{"key":"10.1016\/j.bone.2019.02.019_bb0070","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1146\/annurev.biochem.75.101304.123901","article-title":"Protein misfolding, functional amyloid, and human disease","volume":"75","author":"Chiti","year":"2006","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.bone.2019.02.019_bb0075","doi-asserted-by":"crossref","first-page":"15806","DOI":"10.1073\/pnas.0604035103","article-title":"Characterization of the nanoscale properties of individual amyloid fibrils","volume":"103","author":"Smith","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bone.2019.02.019_bb0080","doi-asserted-by":"crossref","first-page":"13246","DOI":"10.1073\/pnas.1005704107","article-title":"Supramolecular insulin assembly II for a sustained treatment of type 1 diabetes mellitus","volume":"107","author":"Gupta","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bone.2019.02.019_bb0085","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.biomaterials.2014.11.041","article-title":"Novel multimeric IL-1 receptor antagonist for the treatment of rheumatoid arthritis","volume":"42","author":"Pasi","year":"2015","journal-title":"Biomaterials"},{"key":"10.1016\/j.bone.2019.02.019_bb0090","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/978-1-59745-060-7_18","article-title":"Bone marrow-derived mesenchymal stem cells: isolation, expansion, characterization, viral transduction, and production of conditioned medium","volume":"482","author":"Gnecchi","year":"2009","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.bone.2019.02.019_bb0095","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.freeradbiomed.2013.03.004","article-title":"Homocysteine alters the osteoprotegerin\/RANKL system in the osteoblast to promote bone loss: pivotal role of the redox regulator forkhead O1","volume":"61","author":"Vijayan","year":"2013","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bone.2019.02.019_bb0100","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1586\/14737159.2014.901154","article-title":"The workflow of single-cell expression profiling using quantitative real-time PCR","volume":"14","author":"Stahlberg","year":"2014","journal-title":"Expert. Rev. Mol. Diagn."},{"key":"10.1016\/j.bone.2019.02.019_bb0105","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.bone.2011.03.720","article-title":"Impaired bone healing pattern in mice with ovariectomy-induced osteoporosis: a drill-hole defect model","volume":"48","author":"He","year":"2011","journal-title":"Bone"},{"key":"10.1016\/j.bone.2019.02.019_bb0110","doi-asserted-by":"crossref","first-page":"9902","DOI":"10.1038\/s41598-017-09921-8","article-title":"Skeletal site-specific changes in bone mass in a genetic mouse model for human 15q11-13 duplication seen in autism","volume":"7","author":"Lewis","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bone.2019.02.019_bb0115","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/8756-3282(96)00085-3","article-title":"Time-dependent changes in biochemical bone markers and serum cholesterol in ovariectomized rats: effects of raloxifene HCl, tamoxifen, estrogen","volume":"18","author":"Frolik","year":"1996","journal-title":"and alendronate, Bone"},{"key":"10.1016\/j.bone.2019.02.019_bb0120","first-page":"39","article-title":"Alfacalcidol restores cancellous bone in ovariectomized rats","volume":"3","author":"Li","year":"2003","journal-title":"J. Musculoskelet. Neuronal Interact."},{"key":"10.1016\/j.bone.2019.02.019_bb0125","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.6061\/clinics\/2013(10)08","article-title":"Tocotrienol supplementation in postmenopausal osteoporosis: evidence from a laboratory study","volume":"68","author":"Muhammad","year":"2013","journal-title":"Clinics (Sao Paulo)"},{"key":"10.1016\/j.bone.2019.02.019_bb0130","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1007\/s00774-009-0070-x","article-title":"Influence of ferutinin on bone metabolism in ovariectomized rats. I: role in preventing osteoporosis","volume":"27","author":"Palumbo","year":"2009","journal-title":"J. Bone Miner. Metab."},{"key":"10.1016\/j.bone.2019.02.019_bb0135","doi-asserted-by":"crossref","first-page":"335","DOI":"10.4161\/pri.26020","article-title":"32k Da protein improve ovariectomy-induced bone loss in rats","volume":"7","author":"Zhou","year":"2013","journal-title":"Prion"},{"key":"10.1016\/j.bone.2019.02.019_bb0140","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1084\/jem.186.4.489","article-title":"Estrogen inhibits bone resorption by directly inducing apoptosis of the bone-resorbing osteoclasts","volume":"186","author":"Kameda","year":"1997","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bone.2019.02.019_bb0145","doi-asserted-by":"crossref","first-page":"7829","DOI":"10.1073\/pnas.130200197","article-title":"Estrogens suppress RANK ligand-induced osteoclast differentiation via a stromal cell independent mechanism involving c-Jun repression","volume":"97","author":"Shevde","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bone.2019.02.019_bb0150","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.actbio.2018.07.045","article-title":"Inhibition of the fibrillation of highly amyloidogenic human calcitonin by cucurbit[7]uril with improved bioactivity","volume":"78","author":"Shang","year":"2018","journal-title":"Acta Biomater."},{"key":"10.1016\/j.bone.2019.02.019_bb0155","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1172\/JCI6800","article-title":"Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin","volume":"104","author":"Plotkin","year":"1999","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bone.2019.02.019_bb0160","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/0960-0760(90)90497-9","article-title":"Calcitonin, estrogens and the bone","volume":"37","author":"Gennari","year":"1990","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.bone.2019.02.019_bb0165","doi-asserted-by":"crossref","first-page":"13960","DOI":"10.1073\/pnas.251534698","article-title":"Up-regulation of TNF-producing T cells in the bone marrow: a key mechanism by which estrogen deficiency induces bone loss in vivo","volume":"98","author":"Roggia","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bone.2019.02.019_bb0170","doi-asserted-by":"crossref","first-page":"3774","DOI":"10.1210\/endo.141.10.7715","article-title":"Calcitonin receptor regulation and responsiveness to calcitonin in human osteoclast-like cells prepared in vitro using receptor activator of nuclear factor-kappaB ligand and macrophage colony-stimulating factor","volume":"141","author":"Samura","year":"2000","journal-title":"Endocrinology"},{"key":"10.1016\/j.bone.2019.02.019_bb0175","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1002\/jps.2600840610","article-title":"Enhanced potency of human calcitonin when fibrillation is avoided","volume":"84","author":"Cudd","year":"1995","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.bone.2019.02.019_bb0180","first-page":"164","article-title":"Animal models for bone and joint disease. Ovariectomized and orchidectomized animals","volume":"21","author":"Inada","year":"2011","journal-title":"Clin. Calcium"},{"key":"10.1016\/j.bone.2019.02.019_bb0185","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.3945\/jn.108.093781","article-title":"Ovariectomy-induced hyperphagia does not modulate bone mineral density or bone strength in rats","volume":"138","author":"Jiang","year":"2008","journal-title":"J. Nutr."},{"key":"10.1016\/j.bone.2019.02.019_bb0190","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/8756-3282(96)00014-2","article-title":"A comparison of the skeletal effects of intermittent and continuous administration of calcitonin in ovariectomized rats","volume":"18","author":"Li","year":"1996","journal-title":"Bone"},{"key":"10.1016\/j.bone.2019.02.019_bb0195","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1113\/expphysiol.1993.sp003721","article-title":"Osteoclast function and its control","volume":"78","author":"Zaidi","year":"1993","journal-title":"Exp. Physiol."},{"key":"10.1016\/j.bone.2019.02.019_bb0200","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1007\/s00198-009-0882-5","article-title":"Effects of PTH treatment on tibial bone of ovariectomized rats assessed by in vivo micro-CT","volume":"20","author":"Brouwers","year":"2009","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2019.02.019_bb0205","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1172\/JCI45890","article-title":"Normocalcemia is maintained in mice under conditions of calcium malabsorption by vitamin D-induced inhibition of bone mineralization","volume":"122","author":"Lieben","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bone.2019.02.019_bb0210","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1002\/jbmr.5650110405","article-title":"Calcitonin prevents bone loss but decreases osteoblastic activity in ovariohysterectomized beagle dogs","volume":"11","author":"Monier-Faugere","year":"1996","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2019.02.019_bb0215","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1186\/s13018-018-1018-4","article-title":"A multi-factorial analysis of bone morphology and fracture strength of rat femur in response to ovariectomy","volume":"13","author":"Rosales Rocabado","year":"2018","journal-title":"J. Orthop. Surg. Res."},{"key":"10.1016\/j.bone.2019.02.019_bb0220","first-page":"1968","year":"1967","journal-title":"Heinemann, London"},{"key":"10.1016\/j.bone.2019.02.019_bb0225","doi-asserted-by":"crossref","first-page":"5215","DOI":"10.1038\/ncomms6215","article-title":"Calcitonin controls bone formation by inhibiting the release of sphingosine 1-phosphate from osteoclasts","volume":"5","author":"Keller","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bone.2019.02.019_bb0230","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.3892\/mmr.2015.3637","article-title":"Effectiveness of combined salmon calcitonin and aspirin therapy for osteoporosis in ovariectomized rats","volume":"12","author":"Wei","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.bone.2019.02.019_bb0235","doi-asserted-by":"crossref","first-page":"E627","DOI":"10.1152\/ajpendo.00307.2002","article-title":"Human osteoblast-like cell proliferation induced by calcitonin-related peptides involves PKC activity","volume":"284","author":"Villa","year":"2003","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2019.02.019_bb0240","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1006\/bbrc.2000.2294","article-title":"Effect of elcatonin on osteoinduction by recombinant human bone morphogenetic protein-2","volume":"269","author":"Okubo","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bone.2019.02.019_bb0245","doi-asserted-by":"crossref","first-page":"10105","DOI":"10.1073\/pnas.0501215102","article-title":"Rational design of aggregation-resistant bioactive peptides: reengineering human calcitonin","volume":"102","author":"Fowler","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bone.2019.02.019_bb0250","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1002\/jbmr.1869","article-title":"Calcitonin: physiology or fantasy?","volume":"28","author":"Davey","year":"2013","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2019.02.019_bb0255","first-page":"268","article-title":"Calcitonin: discovery, development","volume":"17","author":"Copp","year":"1994","journal-title":"and clinical application, Clin Invest Med"},{"key":"10.1016\/j.bone.2019.02.019_bb0260","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1093\/ckj\/sfv011","article-title":"Calcitonin, the forgotten hormone: does it deserve to be forgotten?","volume":"8","author":"Felsenfeld","year":"2015","journal-title":"Clin. Kidney J."},{"key":"10.1016\/j.bone.2019.02.019_bb0265","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1359\/jbmr.080310","article-title":"Calcitonin receptor plays a physiological role to protect against hypercalcemia in mice","volume":"23","author":"Davey","year":"2008","journal-title":"J. Bone Miner. Res."}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328219300596?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328219300596?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,24]],"date-time":"2019-10-24T14:48:36Z","timestamp":1571928516000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328219300596"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":53,"alternative-id":["S8756328219300596"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2019.02.019","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and characterization of supramolecular calcitonin assembly and assessment of its interactions with the bone remodelling process","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2019.02.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}